You are here: Industry Insights > price

News List

Drug companies are indeed looking at ‘substantial’ price cuts, HHS Secretary Azar tells lawmakers fiercepharma
June 14, 2018
President Donald Trump has previously said some drugmakers will announce “voluntary massive drops” in drug prices, and HHS Secretary Alex Azar just assured lawmakers that pharmas are indeed considering “substantial and material” price cuts.
Price cuts secure NHS place for MS drugs pharmatimes
May 15, 2018
The National Institute for Health and Care Excellence is now backing a trio of therapies to treat relapsing remitting forms of multiple sclerosis (RRMS) after price cuts enabled the cost regulator to endorse their routine use on the NHS.
Price of blockbuster cancer drug Opidivo to be further reduced by 23 percent in Japan biospectrumasia
March 08, 2018
Opdivo is marketed In Japan by Ono Pharmaceuticals
More life-saving medicines to become cheaper by as much as 53% indiatimes
November 27, 2017
NEW DELHI: More essential medicines to treat life-threatening ailments including heart problems, Hepatitis-C and cancer are set to become cheaper, with India’s drug pricing watchdog having capped prices of 51 drugs by as much as 53%.
Puma to price new cancer med Nerlynx at a higher-than-expected $10K per month: report biospectrumasia
July 21, 2017
Shares of Puma Biotechnology have tripled since the start of the year to more than $95, as the Los Angeles company gets set to launch its debut drug, Nerlynx (neratinib) for HER2-positive breast cancer.
To Fight Against The Behavior Between Sinovac's Special Committee And Weidong Yin's Consortium And T en-cphi.cn
June 29, 2017
On the evening of June 26, 2017 Beijing time, Sinovac Biotech Ltd. (Nasdaq: SVA, "Sinovac") announced that Sinovac entered into a Definitive Agreement ("Amalgamation Agreement") for Going-Private Transaction with Weidong Yin's consortium ("Consortium A")
Pfizer hikes U.S. prices of 91 drugs biospectrumasia
June 13, 2017
This is the second time this year that Pfizer has implemented a series of wholesale price increases. The medications include best-selling drugs like Viagra, the erectile dysfunction treatment, and Lyrica for nerve pain.
Price drops make more cancer drugs routinely available europeanpharmaceuticalreview
March 08, 2017
The National Institute for Health and Care Excellence (NICE) is half way through a review of drugs approved and still available only through the old Cancer Drugs Fund (CDF).
J&J to reveal drug price increases next month pharmafile
January 17, 2017
Next month, Johnson & Johnson will reveal the average price increases of its prescription drugs in a move to increase its transparency with patients; the information due to be released by the company will include the list price and net price.

Previous page 1 2 3 4 5 Next page